Home / Pipeline / Tretinoin Gel Microsphere, 0.1% + RETIN-A MICRO® (Tretinoin) Gel Microsphere, 0.1% + Placebo Control Products Tretinoin Gel Microsphere, 0.1% + RETIN-A MICRO® (Tretinoin) Gel Microsphere, 0.1% + Placebo Control
Tretinoin Gel Microsphere, 0.1% + RETIN-A MICRO® (Tretinoin) Gel Microsphere, 0.1% + Placebo Control Phase 1 Completed 💤 Quiet Interest: 29/100
Aug 31, 2020 → Apr 16, 2021
About Tretinoin Gel Microsphere, 0.1% + RETIN-A MICRO® (Tretinoin) Gel Microsphere, 0.1% + Placebo Control Tretinoin Gel Microsphere, 0.1% + RETIN-A MICRO® (Tretinoin) Gel Microsphere, 0.1% + Placebo Control is a phase 1 stage product being developed by Sun Pharmaceutical for Acne Vulgaris. The current trial status is completed. This product is registered under clinical trial identifier NCT04883736. Target conditions include Acne Vulgaris.
What happened to similar drugs? 20 of 20 similar drugs in Acne Vulgaris were approved
Clinical Trials (1) NCT ID Phase Status Start Completion Indication NCT04883736 Phase 1 Completed Aug 31, 2020 Apr 16, 2021 Acne Vulgaris
Product Company Stage Hype Score DFD-03 Dr. Reddy's Laboratories Phase 3 Tazarotene Lotion, 0.1% + Tazarotene Cream, 0.1% Dr. Reddy's Laboratories Phase 2 DFD-03 Lotion, 0.1% + Tazorac Cream, 0.1% + DFD-03 Vehicle Lotion 0% + Tazorac Vehicle Cream 0% Dr. Reddy's Laboratories Phase 2 DFD-03 (0.1% tazarotene) Lotion + DFD-03 (0% tazarotene) Lotion (Placebo) Dr. Reddy's Laboratories Phase 3 Olumacostat Glasaretil Gel, 5.0% Eli Lilly Phase 3 HT-001 2% Topical Gel + HT-001 1% Topical Gel + HT-001 0.5% Topical Gel + HT-001 Placebo Hoth Therapeutics Phase 2 Trifarotene Cream 0.005% + AKLIEF® Cream (Trifarotene 0.005%) US REFERENCE LISTED DRUG + AKLIEF® Cream (Trifarotene 50 mcg/g) CANADIAN REFERENCE PRODUCT + Placebo Sun Pharmaceutical Phase 1 Clindamycin Phosphate and Benzoyl Peroxide Gel, 1.2%/2.5% + Acanya® Gel, 1.2%/2.5% + Vehicle of test product Sun Pharmaceutical Phase 1 Clindamycin 1%/Benzoyl Peroxide 5% Topical Gel + Duac® Topical Gel + Placebo Topical Gel Sun Pharmaceutical Phase 1 Adapalene Gel 0.1% + Placebo Control + Differin® Gel (Adapalene 0.1%, Galderma) Sun Pharmaceutical Phase 1 Trifarotene Cream 0.005% + Placebo + AKLIEF® Cream (Trifarotene 0.005%, Galderma Laboratories) Sun Pharmaceutical Phase 1 Adapalene/BP gel, 0.3%/2.5% + EPIDUO® FORTE + Placebo Sun Pharmaceutical Phase 1 ADPS topical product + Placebo Control Sun Pharmaceutical Phase 2 Isotretinoin Sun Pharmaceutical Approved Winlevi (Clascoterone) cream 1% Sun Pharmaceutical Approved Adapalene Gel 0.3% + Differin® + Placebo Sun Pharmaceutical Phase 1 CLPG Topical Gel 1% + Clindamycin + Placebo Sun Pharmaceutical Phase 1 Adapalene and Benzoyl Peroxide Gel 0.1%/2.5% + Epiduo® Gel + Placebo Sun Pharmaceutical Phase 1 Test. + Aczone Gel 5% + Placebo Sun Pharmaceutical Phase 1 Clindamycin and Benzoyl Peroxide Gel 1%5% + BenzaClin® Topical Gel + Placebo Sun Pharmaceutical Phase 1